Showing results (221-230 of 1,945) with videos related to

Sort By:
Pageof 195
RMD Open|January 29, 2022
Articular manifestations in patients with inflammatory bowel diseases treated with anti-TNFLaurie Cachen, Gaetane Nocturne, Michael Collins, et al.
RMD Open|January 29, 2022
Prevalence and consequences of psoriasis in recent axial spondyloarthritis: an analysis of the DESIR cohort over 6 yearsFlorian Lucasson, Pascal Richette, Krystel Aouad, et al.
RMD Open|January 29, 2022
Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target studyNina Paulshus Sundlisæter, Ulf Sundin, Anna-Birgitte Aga, et al.
RMD Open|February 3, 2022
Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohortAdrian Ciurea, Seraphina Kissling, Kristina Bürki, et al.
RMD Open|November 3, 2021
All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015-2019Vasiliki-Kalliopi Bournia, George E Fragoulis, Panagiota Mitrou, et al.
RMD Open|April 22, 2022
Association between social deprivation and disease activity in rheumatoid arthritis: a systematic literature reviewMrinalini Dey, Amanda Busby, Helen Elwell, et al.
RMD Open|March 17, 2022
Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French Vasculitis Study Group RegistryXavier Puéchal, Michele Iudici, Christian Pagnoux, et al.
RMD Open|March 30, 2022
Patient Reported Outcome Measures for Rheumatoid Arthritis Disease Activity: a systematic review following COSMIN guidelinesTim Pickles, Rhiannon Macefield, Olalekan Lee Aiyegbusi, et al.
RMD Open|April 13, 2022
Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren's syndromeGwenny M Verstappen, Liseth de Wolff, Suzanne Arends, et al.
RMD Open|September 1, 2018
Characteristics and treatment of new-onset arthritis after checkpoint inhibitor therapyJan Leipe, Lisa A Christ, Andreas P Arnoldi, et al.
Pageof 195